{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:26:22Z","timestamp":1788974782555,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.iac.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T20:25:51Z","timestamp":1761769551000},"page":"97-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medical Management of Rhinitis"],"prefix":"10.1016","volume":"46","author":[{"given":"Sylvia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12130","article-title":"Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution","volume":"12","author":"Savour\u00e9","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.otc.2023.09.003","article-title":"Allergic rhinitis and its effect on sleep","volume":"57","author":"Pagel","year":"2024","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.iac.2025.09.007_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2024.111813","article-title":"A meta-analysis of the prevalence and risk of mental health problems in allergic rhinitis patients","volume":"184","author":"Safia","year":"2024","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2500\/ajra.2012.26.3752","article-title":"Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis","volume":"26","author":"Bhattacharyya","year":"2012","journal-title":"Am J Rhinol Allergy"},{"issue":"10","key":"10.1016\/j.iac.2025.09.007_bib5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1398-9995.2008.01750.x","article-title":"Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications","volume":"63","author":"Derendorf","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0145561320967727","article-title":"A scholarly review of the safety and efficacy of intranasal corticosteroids preparations in the treatment of chronic rhinosinusitis","volume":"100","author":"Macias-Valle","year":"2020","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.iac.2025.09.007_bib7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2147\/JAA.S321332","article-title":"Intranasal corticosteroids: topical potency, systemic activity and therapeutic index","volume":"14","author":"Daley-Yates","year":"2021","journal-title":"J Asthma Allergy"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"10.1016\/j.iac.2025.09.007_bib9","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/archinte.161.21.2581","article-title":"Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis","volume":"161","author":"Kaszuba","year":"2001","journal-title":"Arch Intern Med"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2025.09.007_bib10","first-page":"S1","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2020.07.007","article-title":"Rhinitis 2020: a practice parameter update","volume":"146","author":"MS","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4193\/Rhino15.020","article-title":"Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials","volume":"53","author":"Ahmadi","year":"2015","journal-title":"Rhinology"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1183\/09031936.06.00043005","article-title":"Low-dose inhaled and nasal corticosteroid use and the risk of cataracts","volume":"27","author":"Ernst","year":"2006","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/alr.22863","article-title":"Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: a systematic review and meta-analysis","volume":"12","author":"Sampieri","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0194599820931454","article-title":"Intranasal corticosteroid therapy: systematic review and meta-analysis of reported safety and adverse effects in children","volume":"163","author":"Donaldson","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaip.2014.04.008","article-title":"Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis","volume":"2","author":"Lee","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib18","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.2014-1641","article-title":"Intranasal triamcinolone and growth velocity","volume":"135","author":"Skoner","year":"2015","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.iac.2025.09.007_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/WOX.0b013e3181b35322","article-title":"The role of antihistamines in the treatment of vasomotor rhinitis","volume":"2","author":"Lieberman","year":"2009","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jop.1996.12.389","article-title":"The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic\/antihistaminic agent","volume":"12","author":"Yanni","year":"1996","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2500\/ajra.2014.28.4059","article-title":"Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis","volume":"28","author":"Singh","year":"2014","journal-title":"Am J Rhinol Allergy"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2500\/ajra.2013.27.3955","article-title":"Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients","volume":"27","author":"Gawlik","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.iac.2025.09.007_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2025.4283","article-title":"Azelastine nasal spray for prevention of SARS-CoV-2 infections: a phase 2 randomized clinical trial","author":"Lehr","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1185\/030079906X80305","article-title":"Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy","volume":"22","author":"Horak","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.otohns.2007.08.005","article-title":"An assessment of the onset and duration of action of olopatadine nasal spray","volume":"137","author":"Patel","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1081-1206(10)60663-1","article-title":"Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily","volume":"99","author":"Lumry","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425250802670474","article-title":"Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis","volume":"5","author":"Berger","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.anai.2019.03.017","article-title":"Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis","volume":"122","author":"Gross","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2012.01.077","article-title":"A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis","volume":"129","author":"Carr","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1081-1206(10)60408-5","article-title":"Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis","volume":"100","author":"Ratner","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0314-1","article-title":"The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option","volume":"15","author":"Bjermer","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2025.09.007_bib33","first-page":"1426","article-title":"A comparison of health care resource utilization and costs for patients with allergic rhinitis on single-product or free-combination therapy of intranasal steroids and intranasal antihistamines","volume":"22","author":"Harrow","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)63236-X","article-title":"Ipratropium nasal spray in children with perennial rhinitis","volume":"78","author":"Meltzer","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)62620-8","article-title":"Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children","volume":"83","author":"Milgrom","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/108854198778557962","article-title":"The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis","volume":"19","author":"Kaiser","year":"1998","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4065\/77.4.350","article-title":"Use of intranasal cromolyn sodium for allergic rhinitis","volume":"77","author":"Ratner","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0149-2918(02)80009-1","article-title":"Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study","volume":"24","author":"Meltzer","year":"2002","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2222.1985.tb02291.x","article-title":"Exposure of hay fever subjects to an indoor environmental grass pollen challenge system","volume":"15","author":"DAVIES","year":"1985","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pupt.2007.06.007","article-title":"Mechanism of decongestant activity of \u03b12-adrenoceptor agonists","volume":"21","author":"Corboz","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-010-0941-z","article-title":"A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects","volume":"67","author":"Eskiizmir","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib42","first-page":"205","article-title":"Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI","volume":"43","author":"Migneault-Bouchard","year":"2025","journal-title":"Rhinology Journal"},{"key":"10.1016\/j.iac.2025.09.007_bib43","first-page":"113","article-title":"[investigation of the effect of oxymetazoline on the duration of rhinitis. Results of a placebo-controlled double-blind study in patients with acute rhinitis]","volume":"147","author":"Reinecke","year":"2005","journal-title":"MMW Fortschr Med"},{"issue":"11","key":"10.1016\/j.iac.2025.09.007_bib44","first-page":"904","article-title":"Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion","volume":"51","author":"St\u00fcbner","year":"2001","journal-title":"Arzneimittel-Forschung\/Drug Research"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib45","first-page":"9","article-title":"Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity","volume":"34","author":"Graf","year":"1996","journal-title":"Rhinology"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib46","first-page":"148","article-title":"Rhinitis medicamentosa","volume":"16","author":"Ramey","year":"2006","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2500\/105065897782537197","article-title":"An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion","volume":"11","author":"Morris","year":"1997","journal-title":"Am J Rhinol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00016489509133350","article-title":"Four-week use of oxymetazoline nasal spray (nezeril(r)) once daily at night induces rebound swelling and nasal hyperreactivity","volume":"115","author":"Graf","year":"1995","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib49","first-page":"167","article-title":"Treatment with xylometazoline (otrivin) nosedrops over a six-week period","volume":"19","author":"Petruson","year":"1981","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005537-199701000-00010","article-title":"Extended use of topical nasal decongestants","volume":"107","author":"Yoo","year":"1997","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200911-1701OC","article-title":"Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion","volume":"182","author":"Vaidyanathan","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaci.2011.01.037","article-title":"Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis","volume":"127","author":"Baroody","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2025.09.007_bib53","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/alr.23015","article-title":"Combined medical therapy in the treatment of allergic rhinitis: systematic review and meta-analyses","volume":"12","author":"Chitsuthipakorn","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S0022215121003364","article-title":"Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review","volume":"136","author":"Neighbors","year":"2022","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40261-023-01338-8","article-title":"A real-world observational study to evaluate the safety and effectiveness of fluticasone furoate\u2013oxymetazoline fixed dose combination nasal spray in patients with allergic rhinitis","volume":"44","author":"Juvekar","year":"2024","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40272-020-00419-x","article-title":"Antihistamines in the management of pediatric allergic rhinitis: a systematic review","volume":"22","author":"Velentza","year":"2020","journal-title":"Pediatr Drugs"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib57","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinthera.2009.05.017","article-title":"A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis","volume":"31","author":"Bachert","year":"2009","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjorl.2023.03.009","article-title":"Efficacy of different oral H1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials","volume":"89","author":"Hong","year":"2023","journal-title":"Braz J Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib61","doi-asserted-by":"crossref","DOI":"10.1067\/mai.2003.1550","article-title":"First do no harm: managing antihistamine impairment in patients with allergic rhinitis","volume":"111","author":"Casale","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2025.09.007_bib62","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.iac.2025.09.007_bib64","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jaip.2024.05.027","article-title":"Cumulative dose effects of H1 antihistamine use on the risk of dementia in patients with allergic rhinitis","volume":"12","author":"Su","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2025.09.007_bib65","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.jaip.2025.04.059","article-title":"Correlation, causation ,and confounding: how worried should we be about dementia risk and second generation antihistamines?","volume":"13","author":"Prasanna Kumar","year":"2025","journal-title":"J Allergy Clinical Immunology Practice"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib66","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1081-1206(10)61317-8","article-title":"The role of leukotrienes in allergic rhinitis","volume":"94","author":"Peters-Golden","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/lary.27576","article-title":"Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma","volume":"129","author":"De Corso","year":"2019","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.iac.2025.09.007_bib69","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.rmed.2006.02.026","article-title":"Efficacy and safety of montelukast in adults with asthma and allergic rhinitis","volume":"100","author":"Virchow","year":"2006","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib70","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ppul.21018","article-title":"Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions","volume":"44","author":"Bisgaard","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.iac.2025.09.007_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.764279","article-title":"Neuropsychiatric adverse events of montelukast: an analysis of real-world datasets and drug\u2212gene interaction network","volume":"12","author":"Umetsu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib72","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13643","article-title":"Analysis of neuropsychiatric diagnoses after montelukast initiation","volume":"5","author":"Paljarvi","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/jamapediatrics.2024.5429","article-title":"Montelukast use and the risk of neuropsychiatric adverse events in children","volume":"179","author":"Wintzell","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/thorax-2024-221590","article-title":"Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma","volume":"80","author":"Paljarvi","year":"2024","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.iac.2025.09.007_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2024.09.010","article-title":"Neuropsychiatric events related to montelukast and pranlukast in adults with asthma and rhinitis: a 10-year nationwide population-based study","volume":"13","author":"Jo","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40264-017-0607-1","article-title":"Neuropsychiatric events associated with leukotriene-modifying agents: a systematic review","volume":"41","author":"Law","year":"2018","journal-title":"Drug Saf"},{"issue":"11","key":"10.1016\/j.iac.2025.09.007_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21842","article-title":"Meta-analysis of the relationship between montelukast use and neuropsychiatric events in patients with allergic airway disease","volume":"9","author":"Mou","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/000348947708600216","article-title":"Nasal decongestant activity of pseudoephedrine","volume":"86","author":"Roth","year":"1977","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib80","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaip.2015.05.007","article-title":"Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study","volume":"3","author":"Meltzer","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.anai.2015.10.022","article-title":"Phenylephrine hydrochloride modified-release tablets for nasal congestion: a randomized, placebo-controlled trial in allergic rhinitis patients","volume":"116","author":"Meltzer","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib82","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1345\/aph.1H679","article-title":"Efficacy and safety of oral phenylephrine: systematic review and meta-analysis","volume":"41","author":"Hatton","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anorl.2014.11.001","article-title":"Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants","volume":"132","author":"Laccourreye","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib84","first-page":"722","article-title":"A comparative study of the side effects between pseudoephedrine in loratadine plus pseudoephedrine sulfate repetabs tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients","volume":"85","author":"Supiyaphun","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"14","key":"10.1016\/j.iac.2025.09.007_bib85","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.1984.03350140044023","article-title":"Toxicity of over-the-counter stimulants","volume":"252","author":"Pentel","year":"1984","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib86","first-page":"521","article-title":"Visual hallucinations in a toddler: accidental ingestion of a sympathomimetic over the counter nasal decongestant","volume":"15","author":"Sauder","year":"1997","journal-title":"AJEM (Am J Emerg Med)"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0736-4679(98)00193-0","article-title":"Dextromethorphan- and pseudoephedrine-induced agitated psychosis and ataxia: case report","volume":"17","author":"Roberge","year":"1999","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib88","article-title":"Effect of adrenergic agonist oral decongestants on blood pressure","volume":"3","author":"Chan","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"7","key":"10.1016\/j.iac.2025.09.007_bib90","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1398-9995.1987.tb00383.x","article-title":"Treatment of allergic rhinoconjunctivitis in Denmark","volume":"42","author":"Laursen","year":"1987","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70017","article-title":"Prednisolone versus antihistamine for allergic rhinitis: no significant difference found in randomized trial","volume":"15","author":"Skr\u00f6der","year":"2025","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib92","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1378\/chest.128.5.3140","article-title":"Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma","volume":"128","author":"Stelmach","year":"2005","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.iac.2025.09.007_bib93","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/j.1552-4604.1993.tb01957.x","article-title":"Oral methylprednisolone acetate (medrol tablets) for seasonal rhinitis: examination of dose and symptom response","volume":"33","author":"Brooks","year":"1993","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib94","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bjorl.2016.08.009","article-title":"Associa\u00e7\u00e3o entre desloratadina e prednisolona no tratamento de crian\u00e7as com sintomas agudos de rinite al\u00e9rgica: ensaio cl\u00ednico duplo-cego, randomizado e controlado","volume":"83","author":"Wandalsen","year":"2017","journal-title":"Braz J Otorhinolaryngol"},{"issue":"5691","key":"10.1016\/j.iac.2025.09.007_bib95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.1.5691.267","article-title":"Clinical and endocrine side-effects of methylprednisolone acetate as used in hay-fever","volume":"1","author":"James","year":"1970","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib96","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.iac.2025.09.007_bib97","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.rmed.2013.09.007","article-title":"Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes","volume":"107","author":"Aasbjerg","year":"2013","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.iac.2025.09.007_bib98","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.iac.2025.09.007_bib99","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/aje\/153.11.1089","article-title":"Steroids and risk of upper gastrointestinal complications","volume":"153","author":"Hern\u00e1ndez-D\u00edaz","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib100","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib101","first-page":"43","article-title":"Biologics in allergic rhinitis","volume":"27","author":"Bayar Muluk","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.iac.2025.09.007_bib102","first-page":"501","article-title":"Omalizumab for the treatment of allergic rhinitis: a systematic review and meta-analysis","volume":"59","author":"Tsabouri","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.iac.2025.09.007_bib104","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.imlet.2020.08.002","article-title":"Long-term omalizumab efficacy in allergic rhinitis","volume":"227","author":"Cavaliere","year":"2020","journal-title":"Immunol Lett"},{"issue":"5","key":"10.1016\/j.iac.2025.09.007_bib105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.anai.2020.05.026","article-title":"Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis","volume":"125","author":"Busse","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","article-title":"Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma","volume":"142","author":"Weinstein","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2025.09.007_bib107","doi-asserted-by":"crossref","DOI":"10.1159\/000544039","article-title":"Evaluation of rhinological symptoms and quality of life in patients with allergic or eosinophilic severe uncontrolled asthma treated with Anti-IgE or Anti-IL5 therapy: a real-live study","author":"Jura-Szoltys","year":"2025","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.007_bib108","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/jcm13030754","article-title":"Eosinophilic patterns in patients with seasonal allergy affected by bronchial asthma and rhinitis\/rhinosinusitis: efficacy of benralizumab in patients with the persistent pattern","volume":"13","author":"D\u2019Aiuto","year":"2024","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.iac.2025.09.007_bib109","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41591-025-03651-5","article-title":"Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.iac.2025.09.007_bib111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13223-017-0183-z","article-title":"Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from phase 2 and phase 3 randomized, double-blind, placebo- and active-referenced studies","volume":"13","author":"Ratner","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"Suppl 58","key":"10.1016\/j.iac.2025.09.007_bib112","article-title":"QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber","volume":"44","author":"Erpenbeck","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.iac.2025.09.007_bib113","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000528634","article-title":"DPP4 inhibitor sitagliptin reduces inflammatory responses and mast cell activation in allergic rhinitis","volume":"108","author":"Sun","year":"2023","journal-title":"Pharmacology"},{"issue":"8","key":"10.1016\/j.iac.2025.09.007_bib114","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3390\/ijerph16081323","article-title":"Association between dipeptidyl peptidase-4 inhibitors and allergic rhinitis in Asian patients with diabetes","volume":"16","author":"Chen","year":"2019","journal-title":"Int J Environ Res Public Health"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856125000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856125000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:34:06Z","timestamp":1763469246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856125000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0889856125000785"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2025.09.007","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Management of Rhinitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}